Skip to content
Riskpilot
← Back to search
Sign in
Get full access
RexCell Tissue & Airlaid Aktiebolag
AB
Active
Org 5561939769
Brovägen 7-8, 666 40
Skåpafors
Manufacture of paper and paperboard
· NACE 1712
Est. 1976
196 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of paper and paperboard
/
RexCell Tissue & Airlaid Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
419M
839M
1B
2B
766M
2020
836M
2021
1.3B
2022
1.5B
2023
1.3B
2024
EBITDA
SEK millions
0M
126M
251M
377M
503M
144M
2020
113M
2021
267M
2022
437M
2023
309M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
766 088
835 786
1 305 294
1 459 383
1 308 075
Staff expenses
—
—
—
—
—
EBITDA
143 908
112 592
267 455
436 544
309 026
Depreciation & amort.
−35 568
−32 200
−34 144
−36 015
−35 890
EBIT
108 340
80 392
233 311
400 529
273 136
Net financials
−1 184
−394
5 166
19 766
22 682
Profit before tax
−1 705
−4 601
8 282
−659
−1 540
Tax
270
924
−1 187
33
227
Net profit
−1 435
−3 677
7 095
−626
−1 313
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
535 901
601 418
670 928
601 525
618 664
Equity
151 765
148 089
155 184
154 558
153 245
Long-term debt
0
0
0
0
0
Short-term debt
153 021
224 419
284 355
225 772
241 484
Total debt
153 021
224 419
284 355
225 772
241 484
Financial ratios
5-year trend
EBITDA margin
23.6%
This company
15.8%
Market median
+49% vs market
2020
2024
Equity ratio
24.8%
This company
38.2%
Market median
-35% vs market
2020
2024
Return on equity
-0.9%
This company
18.4%
Market median
-105% vs market
2020
2024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
2020
2024
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
2020
2024
Debt / equity
3.04×
This company
0.62×
Market median
-390% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on RexCell Tissue & Airlaid Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
